Secondly, understanding how ADAR rapidly responds to viral infections, how host cells dynamically regulate the concentration of ADAR, and how this “double-edged sword” affects the diverse impact on dsRNAs are crucial for drug design. The gene discussed is ADAR; the disease is viral infectious disease.